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Barrett’s esophagus is an intestine-like metaplasia
and precursor of esophageal adenocarcinoma. Trig-
gered by gastroesophageal reflux disease, the origin
of this metaplasia remains unknown. p63-deficient
mice, which lack squamous epithelia, may model
acid-reflux damage. We show here that p63 null
embryos rapidly develop intestine-like metaplasia
with gene expression profiles similar to Barrett’s
metaplasia. We track its source to a unique embry-
onic epithelium that is normally undermined and re-
placed by p63-expressing cells. Significantly, we
show that a discrete population of these embryonic
cells persists in adult mice and humans at the squa-
mocolumnar junction, the source of Barrett’s meta-
plasia. We show that upon programmed damage to
the squamous epithelium, these embryonic cells
migrate toward adjacent, specialized squamous
cells in a process that may recapitulate early
Barrett’s. Our findings suggest that certain precan-
cerous lesions, such as Barrett’s, initiate not from
genetic alterations but from competitive interactions
between cell lineages driven by opportunity.
INTRODUCTION
Esophageal and gastric adenocarcinoma together kill more than
amillion people each year. Both cancers arise in association with
chronic inflammation and are preceded by robust metaplasia
with intestinal cell characteristics. Gastric intestinal metaplasia
is linked to H. pylori infection, whereas Barrett’s metaplasia of
the esophagus can be triggered by gastroesophageal reflux
disease (GERD). Although H. pylori suppression therapies havecontributed to the recent decline of gastric adenocarcinoma,
the incidence of esophageal adenocarcinoma, especially in the
West, has increased dramatically in the past several decades
(Spechler and Goyal, 1986; Blot et al., 1991; Reid, 1991, Raskin
et al., 1992; Jankowski et al., 1999; Badreddine andWang, 2010;
Reid et al., 2010). Treatments for late stages of these diseases
are challenging and largely palliative, therefore considerable
efforts have focused on understanding the earlier, precancerous
stages of these diseases as a prerequisite to developing
therapeutic approaches. Intestine-like metaplasia is character-
ized by a columnar epithelium containing prominent goblet cells
and cells expressing intestinal markers such as villin and
trefoil factors (TFF1–3). Once established, this metaplasia
appears to be irreversible without ablative treatments (Naef
et al., 1975; Sagar et al., 1995; Barr et al., 1996; Badreddine
and Wang, 2010).
Esophageal adenocarcinoma arises from this metaplasia as
the result of stereotypic genetic and cytological changes that
present as dysplasia, high-grade dysplasia, and finally invasive
cancer, all in a process involving clonal evolution (Raskin et al.,
1992; Jankowski et al., 1999; Haggitt, 1994; Maley et al., 2006;
Leedham et al., 2008). The ontogeny of these metaplasias
remains an intriguing mystery with cogent support for hypoth-
eses suggesting transcommitment of resident squamous stem
cells, migration of cells from lower gastrointestinal sites, coloni-
zation by circulating bone marrow cells, or the reparative emer-
gence of submucosal glands (Souza et al., 2008; Badreddine
and Wang, 2010).
p63 is a p53 homolog that is essential for the self-renewal of
stem cells of all stratified epithelial tissues, including mammary
and prostate glands as well as all squamous epithelia. In p63
null embryos, stratified epithelial tissues are lost or eroded
several days after stratification due to the loss of regenerative
cell populations (Yang et al., 1998, 1999; Senoo et al., 2007).
Indeed the p63 null embryos have been reported to have
idiopathic metaplastic changes in both the esophagus andCell 145, 1023–1035, June 24, 2011 ª2011 Elsevier Inc. 1023
proximal stomach, two normally squamous tissues in the mouse
(Yang et al., 1999; Daniely et al., 2004). The p63 null mouse there-
fore offers a unique opportunity to probe the link between
tissue damage and metaplasia. This mouse rapidly develops
metaplasia with the hallmarks of Barrett’s esophagus. We exam-
ined the molecular properties and evolution of the metaplasia in
p63 null embryos to understand its origins and applied this infor-
mation to adult mouse models, testing the emergence of Bar-
rett’s metaplasia.
RESULTS
Metaplasia in the p63 Null Mouse
p63 embryos develop to term but show absent or dysmorphic
stratified epithelia including epidermis, breast, prostate, and
thymus at birth (Yang et al., 1999; Senoo et al., 2007). To deter-
mine whether similar events occur in the squamous epithelia of
the esophagus and proximal stomach of p63 null embryos, we
examined these regions by histology. The squamocolumnar
junction present at the distal esophagus in humans is shifted
posteriorly in mice due to an extension of squamous epithelium
to the gastric midline, as marked by the limit of p63 immunohis-
tochemistry (Figures 1A and 1B). Although the wild-type embry-
onic day (E) 18 embryo has a mature squamous epithelium in the
proximal stomach, the p63 null embryo shows a remarkably
well-developed columnar epithelium at this site (Figure 1C and
Figure S1 available online). Barrett’s esophagus in humans
also lacks p63 staining unlike adjacent squamous tissues where
p63 strongly decorates basal nuclei (Glickman et al., 2001)
(Figure 1D, top panel). Antibodies to keratin 8 stain human
Barrett’s esophagus as well as the metaplasia in the p63 null
mouse (Figure 1D, bottom panel and Figure S1). Other similari-
ties between human Barrett’s esophagus and the metaplasia in
the p63 null mouse are the positive staining with Alcian blue
and periodic acid-Schiff (PAS), typical histological markers of
goblet-like cells (Figure 1E). We probed the metaplasia and
control tissues for known markers (Wang et al., 2009; Botelho
et al., 2010) of Barrett’s esophagus using antibodies against villin
(Vil1) and anterior gradient 2 (Agr2) in addition to keratin 8 (Krt8),
all of which showed specific and robust staining of the meta-
plasia in the p63 null embryos (Figure S1). The histological
similarity between the observed metaplasia in p63 null embryos
and Barrett’s esophagus in humans drove us to investigate these
tissues at a molecular level.
Gene Expression Profile versus Barrett’s
We compared the gene expression profile of the metaplastic
epitheliawith those of specific regions of the gastrointestinal tract
in mutant and wild-type animals, comparing RNA from
microdissected tissues on expression microarray chips. These
data revealed that the wild-type and p63 null colon, small intes-
tine, and distal stomach formed concordant pairs of overall
gene expression (Figure 2A). In contrast, comparisons of gene
expression betweenwild-type and p63 null proximal stomach re-
vealed stark differences, suggesting that the cells in the observed
metaplasia were clearly distinct from those in normal squamous
epithelia at this site (Figure 2A).Moreover, anunsupervisedcorre-
lation analysis of thewhole genome expression profiles of tissues1024 Cell 145, 1023–1035, June 24, 2011 ª2011 Elsevier Inc.in the p63 null embryos indicated only passing relationships
between the metaplastic tissue and the small intestine
(Figure 2B), suggesting that this metaplasia is a unique entity
unrelated to othermajor tissues of the normalmouse gastrointes-
tinal tract. The distinction between the metaplasia and the small
intestine is underscored by examining gene expression on
a global level as in the correlation coefficient analysis as well as
a selected set of genes expressed in the metaplasia and small
intestine (Figure 2C). Thus although many genes linked to intes-
tinal metaplasia found in Barrett’s are present in the p63 null
metaplasia, many others, including Caudal-type homeobox 2
(Cdx2), are not. A comparison of Cdx2 expression by microarray
intensity across the wild-type and p63 null tissues of the gastro-
intestinal tract revealed Cdx2 expression restricted to the small
intestine and colon of these mice (Figure S2). Cdx2 has been
strongly implicated in the developmental determination of the
intestinal track where it behaves as a haploinsufficient tumor
suppressor and key regulator of intestinal differentiation and
proliferation (Suh and Traber, 1996; Chawengsaksophak et al.,
1997). Significantly, ectopic expression of Cdx2 in parietal cells
resulted in an intestinal metaplasia of transgenic mice,
suggesting a dominant role for this transcription factor in the
transcommitment to intestinal programs (Mutoh et al., 2002).
However, a recent analysis of Barrett’s esophagus by expression
microarray did not reveal enhanced levels of Cdx2 in Barrett’s
over that of normal esophageal squamous epithelium (Stairs
et al., 2008). Cdx2 expression can only be weakly detected in
30%–70%of Barrett’s tissues and only becomes strong in cases
involving dysplasia (van Baal et al., 2008; Weimann et al., 2010).
Moreover, a comparison between human Barrett’s esophagus
and human small intestine shows a similar divide in gene expres-
sion aswe found between the p63 null metaplasia and themurine
small intestine (Figure S2). Together, these data argue that both
Barrett’s esophagus and the p63 null metaplasia are different
entities from other regions of the gastrointestinal tract.
We next asked how the gene expression differences between
wild-type and p63 null proximal stomach compared with two
available, independent datasets (Stairs et al., 2008; Kimchi
et al., 2005) of human Barrett’s metaplasia and normal esoph-
agus (Figure 2D; Table S1). A broad comparison of the mouse
datasets with the two human Barrett’s datasets showed a strong
correlation between the genes differentially expressed in the
metaplasia of the p63 null mouse and those differentially ex-
pressed in Barrett’s esophagus compared with normal human
esophagus (Figure 2D, heatmaps). Interestingly, we found
a remarkable similarity in the overlapping genes in the two human
datasets (Figure 2D, Venn diagrams), even though the Barrett’s
dataset #1 (Stairs et al., 2008) was from Barrett’s biopsies
whereas the Barrett’s dataset #2 was from metaplasias of
patients who had progressed to esophageal adenocarcinoma
(Kimchi et al., 2005). Indeed of the top 50 genes overrepresented
in themetaplasia of themouse proximal stomach, approximately
50%of those present on the human arrayswere overrepresented
in both Barrett’s esophagus datasets compared with normal
human esophagus (1.5-fold cutoff, p < 0.05; Figure 2E; Table
S2). Within these common genes were many of the markers
established for Barrett’s esophagus and gastric intestinal
metaplasia (Wang et al., 2009; Botelho et al., 2010). In fact, the
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Figure 1. Metaplasia in the Proximal Stomach of p63 Null Embryos
(A) Schematic representation of the human and murine upper gastrointestinal tract showing the respective positions of the squamous (red) and glandular tissues
(gray) and intervening squamocolumnar junction.
(B) Histological section through the stomach of an E18 wild-type mouse stained with anti-p63 antibodies highlighting the p63-positive squamous epithelia of the
proximal stomach (PS) and the glandular epithelium of the distal stomach (DS).
(C) Comparison of histologically stained sections through stomachs of E18 wild-type (left panel) and p63 null (right panel) embryos with high-magnification insets
showing squamous tissue lining the proximal stomach of the wild-type mouse and columnar epithelia in the p63 mutant animals.
(D) Histological sections through Barrett’s esophagus with both squamous islands and glands of intestinal metaplasia stained with antibodies to p63 (top panel)
and to the Barrett’s marker Krt8 (bottom panel).
(E) Comparison of Alcian blue and periodic acid-Schiff staining of human Barrett’s esophagus (left panels) and metaplasia in E19 p63 null proximal
stomach (right panels).
See also Figure S1.
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Figure 2. Gene Expression of Metaplasia in p63 Null Embryos
(A) A three-dimensional representation of a principle component analysis of expression microarray data derived from gastrointestinal tract tissues of E18 wild-
type (WT) and p63 null (KO) embryos. PS, proximal stomach; DS, distal stomach; LI, large intestine; SI, small intestine.
(B) Heatmap of expression microarray data from gastrointestinal tract anchored by a comparison between wild-type and p63 null proximal stomach datasets.
(C) Hierarchical correlation analysis of whole genome datasets from wild-type and p63 null tissues. Histogram depicts expression profiles of genes selected to
emphasize metaplasia-specific and intestine-specific genes. Error bars indicate standard deviation of the mean.
(D) Heatmaps of differentially expressed genes in wild-type and p63 null proximal stomach and corresponding expression patterns in two different datasets
of normal human esophagus and Barrett’s metaplasia (Barrett’s #1 from Stairs et al., 2008; Barrett’s #2 from Kimchi et al., 2005). Below, Venn diagrams showing
the overlap of genes from the two Barrett’s dataset that are also high (or low) in the p63 null metaplasia.
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Figure 3. Retrospective Tracing of Meta-
plasia through Embryogenesis
(A) Fluorescence micrographs of metaplasia in
proximal stomachs of p63 null embryos from E19
to E13, stained with antibodies to Cldn3, Krt7, Krt8,
and Car4 and counterstained with Hoechst dye for
DNA (blue).
(B) Sections through the proximal stomachs of E13
p63 null (left) and wild-type (right) embryos stained
with antibodies to Car4 (green), showing a simple
columnar epithelium lining the lumen. Insets at
higher magnification. Sections counterstained with
Hoechst dye for DNA.
See also Figure S4.fold-change in these genes in the p63 null metaplasia (mucin 4
[Muc4, 733], keratin 20 [Krt20, 613], trefoil factor 2 [TFF2, 493],
claudin 3 [Cldn3, 463], Agr2 [1203], and Vil1 [273]; p < 105 for
all) greatly exceeded those in the Barrett’s datasets (Table S2).
We used antibodies to Agr2 and Vil1 to validate some of these
genes, and both showed robust staining of themetaplastic tissue
in the p63 null proximal stomach (cf. Figure S1).
To validate some of these markers upregulated in the meta-
plasia of the p63 null mouse with human Barrett’s esophagus,
we stained sections of 16 cases of Barrett’s esophagus and
controls with antibodies to human keratin 7 (Krt7), keratin 8
(Krt8), Vil1, Cldn3, Fc fragment of IgG-binding protein (FCGBP),
Muc4, and Agr2. All 16 Barrett’s esophagus cases were positive
for all of thesemarkers, whereas antibodies to p63 showed stain-
ing restricted to squamous islands (Figure S3).
Finally, we compared the gene expression datasets of the
murine metaplasia and the human Barrett’s esophagus at the(E) Scatterplot of upregulated genes in Barrett’s esophagus from two different datasets that are also in the to
null mouse. Pie chart indicates relative intersection of 35 most overexpressed genes of p63 null metaplasia
See also Figure S2, Figure S3, Table S1, Table S2, and Table S3.
Cell 145, 1023–103level of gene ontology. Of the 63 gene
ontology (GO) categories significantly
(p < 0.01) represented in the metaplasia
of the mice and the 42 identified for
Barrett’s esophagus, 34% or 54% were
in common (Figure S3; Table S3). These
findings, although broadly based, sug-
gest that similar processes are occurring
in the cells of the p63 null metaplasia
and those of Barrett’s esophagus.
Embryonic Origin of Metaplasia
in the p63 Null Mouse
In an effort to clarify the source of the
epithelial metaplasia observed in the
E18 p63 null mouse, we traced markers
common to both Barrett’s esophagus
and our metaplasia retrospectively
through embryonic development. Anti-
bodies to Cldn3, Krt7, Krt8, carbonic an-
hydrase 4 (Car4), and Muc4 were used totrace the metaplasia from E19 to E13 (Figure 3A; Figure S4).
Each of these markers could be traced in the proximal stomach
of the E13/E14 p63 null mouse to a monolayer of cells lining the
proximal stomach. Curiously, whereas Cldn3, Krt7, Krt8, and
Muc4 signals became weaker as one approached E13, the
Car4 antibody signal was more robust and broadly expressed
on this monolayer of cells at E13. When we compared the
Car4 staining pattern on the p63 null and wild-type proximal
stomach at E13, both yielded a similarly appearing, Car4-ex-
pressing columnar epithelium (Figure 3B). Thus the Car4-posi-
tive, columnar epithelium at E13 must represent a ground state
for the metaplasia that emerges later in the proximal stomach of
the p63 null mice.
Why do the p63 null embryos go on to develop a Barrett’s-like
metaplasia while the wild-type embryos do not? p63 is a tran-
scription factor required for long-term self-renewal of stem cells
of stratified epithelia but not for their commitment to stem cellsp 50 overexpressed genes in metaplasia of the p63
with the Barrett’s datasets.
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Figure 4. Undermining of Car4 Cells by p63-Positive Cells at E14
(A and B) Sections through wild-type E13 and wild-type E14 proximal stomachs, respectively, probed with antibodies to Car4 and p63. Green arrow depicts an
apparent anterior-to-posterior gradient of p63-positive cells from esophagus to proximal stomach.
(C) Top left panel: Section through anterior portion of wild-type E14 stomach showing Car4 cells (red) atop p63 cells (green) and corresponding section stained
with antibodies to Ki67 (red; lower left panel). Top right panel: Car4 cells (red) in direct contact with basement membrane in distal regions lacking p63 cells. Lower
right panel: Corresponding section stained with antibodies to Ki67 (red).
(D) Schematic depicting hypothetical undermining of Car4 cells (red) by proximal migration of p63 cells (green).
(E) Imaging of E14 proximal stomach epithelium in sections of p63 null embryo with antibodies to Car4 (green, left panel), Claudin 3 (red, middle panel), and Ki67
(red, right panel).nor for their differentiation (Yang et al., 1998, 1999; Senoo et al.,
2007). In wild-type embryos, strong p63 expression is first de-
tected at E13 in a population of cells in the esophagus, and
this expression is notably weaker in cells that extend distally
toward the Car4 cells (Figure 4A). By E14, the p63-positive cells
appear to extend to and actually among and under the
Car4/Cldn3-positive cells in an anterior-posterior gradient1028 Cell 145, 1023–1035, June 24, 2011 ª2011 Elsevier Inc.(Figure 4B), such that many of the Car4/Cldn3 cells are displaced
from the basement membrane to an apical position with
respect to the p63-expressing cells. Remarkably, whereas the
Car4-expressing cells positioned on the basement membrane
at the posterior end of this gradient are highly proliferative (Fig-
ure 4C, right panel), those undermined by p63-expressing cells
show reduced cell-cycle activity (Figure 4C, left panel). Car4 cells
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Figure 5. Persistence of Embryonic Cells
at the Squamocolumnar Junction
(A) Distribution of the Krt7 (green) and Krt5 (red)
expressing cells in wild-type embryos from E13 to
E19. Although originally a columnar epithelium at
E13 and E14, these cells assume a supra-
squamous position at E15 and ultimately disinte-
grate as a suprasquamous cell layer at E18,
except for the squamocolumnar junction where
they persist in all six embryos tested.
(B) Histology section through the squamoco-
lumnar junction of a wild-type 3-week-old mouse
bordered by the proximal stomach (PS) and the
distal stomach (DS).
(C) Heatmap of genes differentially expressed in
the proximal stomach, the junction, and the distal
stomach.
(D) Venn diagram of intersection between genes
highly expressed in the junction versus the
metaplasia of the p63 null mouse.
(E) Heatmaps of genes overexpressed in common
between themetaplasia of the p63 null mouse (KO
proximal stomach versus WT proximal stomach),
the squamocolumnar junction of the wild-type
adult mouse (WT junction versus WT proximal
stomach), and Barrett’s esophagus (BE versus
normal human esophagus).
See also Figure S5 and Table S4.with direct access to the basement membrane at E14 had
a proliferation index greater than 65%, whereas those under-
mined by p63-expressing cells showed a proliferation index of
approximately 10%, suggesting a mechanism by which the
p63 cells prevent the Car4 cells from evolving into a proliferative
metaplasia (Figure 4D). Taken together with the metaplasia
tracing using five independent markers (cf. Figure 3A; Figure S4),
these data suggest a model in which the metaplasia in the p63
null mouse arises from the Car4 cells that lie on the basement
membrane of the proximal stomach. We suggest that the
Car4-positive primitive epithelium develops into a metaplasia
after E14 because of the absence of an undermining population
of squamous epithelium from the esophagus in the p63 null
embryos. In support of this concept, the Car4 cells are not under-
mined by epithelial cells in the p63 null mouse at E14 and instead
appear to rapidly progress to a proliferative columnar epithelium
(Figure 4E). A similar loss of p63 in stem cells of the epidermis
and thymus results in a defect in self-renewal capacity of those
squamous tissues (Yang et al., 1999; Senoo et al., 2007) but no
metaplasias. These earlier studies demonstrated that epidermal
and thymic epithelial stem cells lose self-renewal capability yet
undergo complete and proper differentiation in the absence of
p63. Consistent with these findings, we found no evidence ofCell 145, 1023–103squamous differentiation at any stage of
the metaplasia (Figure S4). Together,
these observations reveal that the Car4
cells that comprise the simple epithelium
of the E13 proximal stomach are tempo-
rally and spatially distinct from the p63-
expressing cells first seen in the E13
esophagus. Therefore in the p63 nullembryo, this Car4 epithelium evolves to yield a Barrett’s-like
metaplasia independent of a transcommitment mechanism. As
well, our data suggest an essential role of p63-positive cells in
the competitive displacement of the Car4 cells from the base-
ment membrane during development (Figures 4B and 4C).
Car4 cells persist in the E18 and E19 metaplasia, though as
a discrete population of small cells that do not express Krt7
and appear strongly associated with the basement membrane
(not shown).
Embryonic Epithelium Is Retained into Adulthood
To determine the ultimate fate of the primitive epithelial cells
undermined by the p63-positive cells at E14, we used antibodies
to Krt7 and Krt5 to follow them from E13 to E19 in wild-type mice
(Figure 5A). Between E15 and E17, the primitive epithelial cells
maintain their apical position above the stratifying squamous
epithelia in the proximal stomach (Figure 5, E15–E17). However,
at E18, these cells undergo an abrupt andwholesale detachment
in large sheets from the underlying epithelia (Figure 5A, E18).
At E19, the Krt7-expressing cells are absent from the entire
proximal stomach with the exception of a discrete population
of cells, numbering approximately 30 in cross-section, remaining
precisely at the squamocolumnar junction (Figure 5A, E19).5, June 24, 2011 ª2011 Elsevier Inc. 1029
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Figure 6. Residual Embryonic Cells in Human Tissues
(A) Immunofluorescence imaging of section of human 21-week-old esophagus
showing suprasquamous distribution of Krt7 (green), Muc4 (green), and Krt5
(red). These results were consistent in the three independent fetuses tested.
(B) Expression of Krt7 (green), Krt5 (red), and Muc4 (green) cells in section of
gastresophageal junction from adult human without Barrett’s esophagus. This
result was consistent in the sections from three individuals tested.Interestingly, occasional Car4-expressing cells appear at the
basement membrane in association with the more numerous
Krt7 cells at the junction, suggesting that this subpopulation of
cells plays some functional role among these junctional cells
(not shown). To probe for junction-specific genes that might
mark these cells, we performed a transcriptome analysis of
RNA derived by dissection of the squamocolumnar junction
and the adjacent squamous and columnar epithelia of a 3-
week-old mouse (Figure 5B). A three-way comparison of junc-
tional genes and the adjacent proximal and distal stomach re-
vealed a set of genes specific to the junction (Figure 5C). A
broader comparison of genes overrepresented in the junction
compared to the wild-type proximal stomach revealed a 38%
overlap with those of the metaplasia of the p63 null proximal
stomach (Figure 5D). We confirmed that two of these, Muc4
and chorioembryonic antigen cell adhesionmolecule (CEACAM),
were present in the squamocolumnar junctions of wild-type adult
mice and in the metaplasias of E18 p63 null mice (Figure S5). A
separate comparison between genes significantly (p < 0.05)
high in the junction versus p63 null metaplasia versus those
high in Barrett’s esophagus revealed a consensus overlap of
87 genes represented as heatmaps (Figure 5E; Table S4). These
genes include some of the key markers of Barrett’s esophagus
including Spink4, Agr2, TFF1, TFF2, Krt8, Krt18, and Vil1, among
others (Figure 5E and Table S4).
The Barrett’s-like metaplasia in the p63 null mouse arose from
a primitive epithelium that is ultimately displaced in the wild-type
animal by the stratification of underlying squamous epithelium at
all sites except the squamocolumnar junction. We asked
whether this mouse model could predict the developmental
dynamics of a similar primitive epithelium in humans. We first
examined histological sections of 21-week-old human fetal
esophagi for the presence of markers of the primitive epithelium
and Barrett’s such as Krt7 and Muc4. Remarkably these anti-
bodies revealed a single layer of suprasquamous epithelia very
similar to that observed in wild-type E15–E17 mouse embryos
(Figure 6A). In the adult human gastroesophageal junction,
however, only junctional cells stain positive for these Barrett’s
markers (Figure 6B). These observations, taken together,
suggest a similar developmental mechanism for the retention
of embryonic epithelium at the gastroesophageal junction in
adult mice and humans.
Modeling Early Steps toward Metaplasia
The persistence of a population of primitive epithelial cells at the
squamocolumnar junction with a lineage relation to an embry-
onic version of a Barrett’s-like metaplasia raised the possibility
that they were related somehow to the clinical observations
that Barrett’s metaplasia always extends from the squamoco-
lumnar junction (Figure 7A). This possibility was further sup-
ported by our analysis of squamocolumnar junctional datasets
in 3-week-old mice, which revealed a discrete population of
keratin 6 (Krt6)-expressing squamous epithelium bordering the
Krt7-expressing embryonic epithelium (Figure 7A). Although
the function of this Krt6-expressing squamous epithelium is
unknown, it further suggests unexpected order at the junction
around the primitive junctional epithelium. To test the hypothesis
that these primitive junctional epithelial cells are the origins of1030 Cell 145, 1023–1035, June 24, 2011 ª2011 Elsevier Inc.a Barrett’s-like metaplasia, we asked how they would react if
we weakened the squamous epithelium as would chronic acid
reflux in humans. We therefore generated mice in which diph-
theria toxin A (DTA) was conditionally expressed in basal cells
of stratified epithelia by crossing the ROSA26-tm-DTA mouse
(Ivanova et al., 2005) with one having a Tamoxifen-dependent
Cre recombinase under the control of the Krt14 promoter
(Vasioukhin et al., 1999) (hereafter the DTA-Krt14Cremouse; Fig-
ure 7B). Treatment of 3-week-old DTA-Krt14Cre mice with
Tamoxifen resulted in a rapid and reproducible expansion of
the Krt7-expressing cells from their ordered appearance at the
squamocolumnar junction to more anterior regions of the prox-
imal stomach among the Krt6-positive cells (Figure 7C and Fig-
ure S6). This observation was absolute, in that all 258 junctional
sections from 14 Tamoxifen-treated mice showed this anterior
migration of Krt7-positive cells, whereas none of the 51 junc-
tional sections from 3 noninjected mice showed this phenom-
enon. Similar staining patterns were obtained with antibodies
to CEACAM to mark the same population recognized by Krt7
(Figure S6). Despite the apparent migration of the Krt7 cells,
we did not observe in the short duration of these experiments
a migration of the relatively rare Car4 cells from these junctions
(not shown). The Krt7 cells did not stain with loricrin, a marker
of differentiated squamous cells, suggesting that the migrating
Krt7-positive cells do not have squamous properties (Figure S6).
Significantly, as the Krt7-expressing cells migrated anteriorly,
some of them came to be in intimate association with the base-
ment membrane, which had been presumably vacated by basal
cells killed as a consequence of Cre-mediated DTA expression.
Although the long-term analysis of these mice was precluded by
the collateral damage to all stratified epithelia due to Krt14-
driven Cre recombinase, the anterior migration of the Krt7 cells
is consistent with the known junctional origins of Barrett’s meta-
plasia following chronic acid reflux in humans.
DISCUSSION
The work presented here models the evolution of a Barrett’s-like
metaplasia in both embryonic and adult mice from precursor
cells that are associated by lineage. The mechanisms by which
these metaplasias arise in embryos and adults are remarkably
similar and suggest a fundamentally novel evolution of precur-
sors of certain cancers in which the earliest events depend not
on genetic changes but rather on competition between cell line-
ages for access to basement membrane (Bissell et al., 2002)
essential for proliferation (Figure 7D). The strongest support for
this notion is the speed by which the metaplasias arise in our
models. In the relatively short interval between embryonic day
13 and day 19, the proximal stomach epithelium of the p63 null
mouse undergoes a robust transition to a Barrett’s-like meta-
plasia. If extrapolated to the human condition this model would
suggest that Barrett’s too could initiate in the absence of acti-
vating mutations typically linked to chronic insults and inflamma-
tion (Schetter et al., 2010). The more salient initial role for chronic
inflammation might be in altering the competitive status quo
between indigenous and opportunistic cell populations as
opposed to the genetic reprogramming of either of them. Once
established, it is clear that Barrett’s metaplasia evolves along
complex pathways in which inflammation drives proliferation-
induced mutations and epigenetic changes that become the
basis of the observed clonal selection (Spechler and Goyal,
1986; Blot et al., 1991; Raskin et al., 1992; Antonioli and Wang,
1997; Jankowski et al., 1999; Glickman et al., 2001; Coad
et al., 2005; Maley et al., 2006; Leedham et al., 2008; Badreddine
andWang, 2010). It will be important to understand what proper-
ties of the metaplastic cells render them so susceptible to
dysplastic progression and malignancy.
The opportunistic cells we implicate in this rapid evolution of
a precancerousmetaplasia contrast with the dominant ‘‘transdif-
ferentiation’’ model that holds that acid reflux triggers the inap-
propriate activation of genes governing intestinal differentiation,
such as Cdx2 in the stem cells of the esophageal squamous
epithelium (reviewed in Souza et al., 2008). The Cdx2 transdiffer-
entiation model for Barrett’s was adapted from a murine model
of gastric intestinal metaplasia in which Cdx2 expression was
ectopically driven in parietal cells from an H+/K+-ATPase
promoter (Mutoh et al., 2002). However, the intestinal metaplasia
in theCdx2mouse has adsorptive properties similar to the intes-
tine whereas Barrett’s esophagus is known to be a secretory
metaplasia (Levine et al., 1989; Dixon et al., 2001; Tobey et al.,
2007). Additionally, Cdx2 expression in Barrett’s without
dysplasia is variable at best and not an absolute feature ofBarrett’s gene expression profiles (van Baal et al., 2008; Stairs
et al., 2008; Weimann et al., 2010). The current study presents
several lines of evidence against a squamous stem cell transdif-
ferentiation model irrespective of Cdx2 and in favor of an embry-
onic origin of the premetaplastic cell.
First, we show by marker tracking that the metaplasia in the
E19 p63-deficient embryos is derived from a group of Car4-ex-
pressing cells lining the proximal stomach at E13. Significantly,
an apparently identical group of Car4-positive cells is seen in
wild-type E13 mouse embryos that is temporally and topologi-
cally distinct from p63-expressing cells arising in the esophagus
that represent precursors to the squamous epithelium. Probably
the most telling evidence comes from the analysis of wild-type
embryogenesis in which the Car4 cells and p63-expressing cells
can be tracked independently and indeed simultaneously
following their laminated interactions from E14 to E17 when the
Car4 progeny are eliminated from the squamous surface except
at the squamocolumnar junction. Finally, we show that cells in
the normal squamocolumnar junction of mice share gene
expression signatures with fully developed metaplasia in the
p63 null mouse, suggesting that these junctional cells, rather
than any form of transdifferentiated squamous cells, are the
origin of this Barrett’s-like metaplasia.
It is probably important as well to dispel the notion that the
Barrett’s-like metaplasia arises from squamous stem cells that
lack p63 in the p63 null mouse. p63 is a master regulator of
self-renewal of stem cells of all stratified epithelia including
mammary and prostate glands as well as skin but appears
dispensable for lineage commitment or differentiation (Yang
et al., 1999; Senoo et al., 2007). Indeed p63 null squamous
tissues such as the epidermis and thymus still undergo normal
differentiation as evidenced by loricrin and involucrin in the
epidermis and the acquisition of functionally mature antigen
presentation cells and normal T cell maturation in the thymus
(Senoo et al., 2007). Thus the most relevant effect of the loss
of p63 in the epidermis and thymus is the diminution of stem
cell self-renewal, whereas transdifferentiation events were not
observed. A similar effect of the loss of p63 in the squamous
stem cells present in the esophagus at E13 would explain the
absence of squamous progenitors that normally undermine
and suppress the uncontrolled growth of the Car4 cells in the
proximal stomach. We believe that this developmental scenario
for the evolution of a Barrett’s-like metaplasia is one where the
competition between squamous progenitors and the Car4 cells
has been biased by limiting squamous cell self-renewal and is
an extreme proxy for our adult mouse model and indeed for
acid-reflux-induced Barrett’s. It is anticipated that this competi-
tion between resident and opportunistic cell populations might
have broader implications for the initiation of premalignant
lesions linked to chronic inflammatory diseases.
Whether other cancers arise by the competitive mechanism
proposed here for Barrett’s is unclear. Most cases of gastric
adenocarcinoma are thought to develop from an ‘‘intestine-
like’’ metaplasia very similar to Barrett’s that develops from
multiple sites in the gastric epithelium secondary to H. pylori
infection (Piazuelo et al., 2004; Correa and Chen, 1994; Goldenr-
ing et al., 2010), though it still remains to be examined whether
they too are derived from residual embryonic cells. It is alsoCell 145, 1023–1035, June 24, 2011 ª2011 Elsevier Inc. 1031
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Figure 7. Damage-Induced Activation of the Residual Primitive Epithelium in Adult Mice
(A) Left: Section through normal junction of adult mouse stained with anti-Krt14 antibodies to reveal squamous epithelia (red) and anti-Krt7 antibodies to detect
residual embryonic cells (green). Right: Junctional section stained with anti-p63 antibodies to reveal squamous basal cells (green) and anti-Krt6 antibodies to
stain specialized junctional squamous cells (red).
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becoming apparent that pancreatic intraepithelial neoplasia, an
intestine-like metaplastic precursor of pancreatic adenocarci-
noma, arises from a set of ductal glands expressing embryonic
features (Strobel et al., 2010). Other candidates for a competitive
or opportunistic mechanism include the unusual neoplasms
associated with inflammatory bowel disease (IBD), including
Crohn’s disease and ulcerative colitis. IBD patients have a high
incidence of aggressive tumors from inflamed regions of both
the large and small intestines with clinical and genetic features
distinct from sporadic colorectal carcinoma (Kiran et al., 2010;
Farraye et al., 2010).
In addition to highlighting a role for embryonic cell populations
in the rise of precancerous lesions, the work presented here
suggests adaptive host mechanisms to suppress the expansion
of such populations. Although speculative, the apparent
mustering of keratin 6-expressing squamous cells, a marker of
keratinocytes involved in wound healing (Wojcik et al., 2001;
Wong and Coulombe, 2003), to sites adjacent to the residual
embryonic epithelium is unlikely to be coincidental. Given that
only a small fraction of individuals with gastroesophageal reflux
actually develop Barrett’s metaplasia, further understanding of
host defenses might reveal new insights into risk profiles.
Finally, the dim prognosis for esophageal adenocarcinoma
argues for therapies directed at preventing even the initiation of
the precancerous but tenacious Barrett’s metaplasia, especially
if the risk status of patients can be stratified by genetics. It is
unclear at presentwhether the residual embryonic cells observed
at the squamocolumnar junction serve any function in situ or
indeed are essential to nucleate Barrett’s metaplasia in response
to GERD. Further studies will be necessary to determine whether
they represent targets for pre-emptive therapeutic strategies in
the normal population to prevent the onset of Barrett’s.
EXPERIMENTAL PROCEDURES
Animal Models
p63/ mice used in this study have been described (Yang et al., 1999). The
heterozygousDTA-Krt14-Crestrainwasgeneratedbycrossing thehomozygous
Gt(ROSA)26Sor< tm1(DTA)Jpmb> /Jstrain (Ivanovaet al., 2005; JacksonLabo-
ratory) with the homozygous Tg(KRT14-cre/Esr1)20Efu/J (Vasioukhin et al.,
1999; Jackson Laboratory). Diphtheria toxin A expression was transcriptionally
activated in basal cells of stratified epithelia by intraperitoneal injections of
Tamoxifen in corn oil (100 mg/kg) for 1–3 weeks prior to analysis. Animals
were handled in accordance with guidelines of the Harvard Medical School
and the Biomedical Resource Center, A*STAR, Singapore. Paraffin sections of
human gastrointestinal junctions and Barrett’s metaplasia were obtained from
archives at the Brigham and Women’s Hospital and the National University of
Singapore Health Services under their respective IRB approvals.
Expression Microarrays and Bioinformatics
RNA processing and hybridization were performed on Affymetrix Mouse
Genome 430 2.0 Array chips at theMicroarray Core at the Dana Farber Cancer(B) Schematic of the DTA-Krt14Cremouse strain constructed to assess the effect
following injections of Tamoxifen over 1 to 3 weeks.
(C) Left: Micrograph depicting the apposition of Krt6-expressing squamous epithe
junction of a 3-week-old mouse that has not received Tamoxifen injections. Ri
beneath the Krt6-positive squamous cells (red) at the junction following 1 week o
(D) Schematic in which chronic acid reflux damages squamous tissues and ind
normally reside at the junction. Krt6-expressing squamous cells are shown in red
See also Figure S6.Institute. All Cel files were processed using GeneChip Operating Software to
calculate probe set intensity values, and probe hybridization ratios were calcu-
lated using Affymetrix Expression Console Software to validate sample quality.
These intensity values were log2-transformed and then imported into the
Partek Genomics Suite 6.5 (beta). A one-way ANOVA was performed to iden-
tify differentially expressed genes. Fold-changes and p values for probe sets
were calculated for each analysis. Principal component analysis (PCA) was
carried out using all probe sets, and heatmaps were generated using sorted
datasets based on Euclidean distance and average linkage methods. Gene
expression datasets from normal and Barrett’s esophagus (Stairs et al.,
2008; Kimchi et al., 2005) were downloaded from the Gene Expression
Omnibus (GEO) genesets of the NCBI. Barrett’s metaplasia datasets showing
squamous cell gene expression were excluded from the analysis.
Histology and Immunofluorescence
Histology, immunohistochemistry, and immunofluorescence were performed
using standard techniques, processed at the Rodent Histopathology Core of
the Dana Farber Harvard Cancer Center, and imaged at the Nikon Imaging
Facility at the Harvard Medical School.
SUPPLEMENTAL INFORMATION
Supplemental Information includes six figures and four tables and can be
found with this article online at doi:10.1016/j.cell.2011.05.026.
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